✨ Free AI Report
Abridge: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Abridge
Company Research

Abridge: Business Overview, Financials & Competitive Analysis

Abridge scores 9/10 on the AskCyborg Cyborg Score (Exceptional). Abridge dominates the high-growth ambient AI medical scribe market with proven enterprise adoption, strategic Epic integration, and a path to $250B+ revenue cycle optimization. Abridge raised a $300 million Series E round in June 2025 at a $5.3 billion post-money valuation, marking a nearly twofold increase in valuation in just four.

What is Abridge's industry? Abridge (abridge.com) operates in Healthcare IT Services. AskCyborg classifies Abridge under Healthcare IT Services in its company registry.

Abridge transforms doctor-patient conversations into structured clinical documentation through an AI system that records the conversation and within minutes produces a complete medical note in SOAP format (Subjective,...

9/ 10Exceptional

Cyborg Score thesis

Abridge dominates the high-growth ambient AI medical scribe market with proven enterprise adoption, strategic Epic integration,...

Read the full analyst-debate transcript →
Industry Healthcare IT Services
6 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 12, 2026
AI-Verified Research
30+ Page Report

Get the Latest Abridge Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Abridge

AskCyborg analysts argue the bull and bear cases for Abridge across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Abridge OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Abridge Overview

Pro stress-test →

Abridge transforms doctor-patient conversations into structured clinical documentation through an AI system that records the conversation and within minutes produces a complete medical note in SOAP format (Subjective, Objective, Assessment, Plan). The company currently has over 150 health systems using its generative AI technology to improve the capture of more than 50 million clinical conversations across 55 specialties and 28 languages.

Strategic Profile

Pro stress-test →

Abridge's primary go-to-market advantage stems from giving Epic both an equity stake and ongoing revenue share, securing preferential access to 38% of all hospital networks that use Epic, positioning them as the default AI scribe in Epic-owned systems like Mayo, Kaiser, and Duke. The company plans to use funding as of 2026-07-27 to transform clinical documentation and revenue cycle workflows by scaling its platform to provide revenue cycle intelligence earlier in clinical conversations and eliminate the need for manual and delayed coordination between clinicians and billing teams.

Competitive Landscape

Pro stress-test →

Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software. Top competitors include Tandem Health, voize, and DeepScribe. Competitors like Nuance and Augmedix offer more comprehensive solutions by incorporating medical coding support and covering a wider range of specialties.

Industry Context

Abridge operates in Healthcare IT Services.

Key facts

Founded: 2018 · Headquarters: Pittsburgh, US · Employees: 200+ · Revenue: Estimated $40M-$60M based on $117M contracted annual recurring revenue (Q1 2025); actual revenue recognition pending · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Abridge.

  • In Q1 2025, Abridge reached $117 million in contracted annual recurring revenue (a metric that includes all signed recurring contracts, including from customers that have still not been onboarded). This signals strong enterprise demand and signals significant future revenue recognition.
  • Abridge was named KLAS #1 Market Leader for Ambient AI in Revenue Cycle Management for the second consecutive year in February 2026. This reinforces competitive moat and validates expansion into revenue cycle workflows.
+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Named KLAS #1 Market Leader for Ambient AI in Revenue Cycle Management for second consecutive year
  • January 2026Partnership with Availity to automate prior authorization at the point of conversation
  • +2 moreTrack every material event for Abridge as it happens. Explore monitoring →
Get alerted when Abridge has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

AmbienceAmbient AI clinical documentation with medical coding support→SukiAI clinical assistant for note generation, coding recommendations, and medical Q&A→DeepScribeAmbient AI medical scribe platform→Tandem HealthAmbient AI clinical documentation platform→NablaAI assistant for clinical documentation with international reach and strong comparative research→Heidi HealthAI medical scribe with product-led model and broad international clinician adoption→

Compare Abridge with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Abridge operates in Healthcare IT Services. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare IT Services research →
NEW · MCP server

Ask your AI assistant about Abridge

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Abridge and its top competitor on Cyborg Score”
“What did Abridge do this quarter?”
“Is Abridge a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Abridge do?+
Abridge transforms doctor-patient conversations into structured clinical documentation through an AI system that records the conversation and within minutes produces a complete medical note in SOAP format (Subjective,...
What is Abridge's Cyborg Score?+
Abridge has a Cyborg Score of 9/10 (Exceptional). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Abridge's main competitors?+
Named competitors include Ambience, Suki, DeepScribe, Tandem Health. The full competitive landscape is in the AskCyborg report.
How can I get the full Abridge research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Abridge research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Abridge over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.